BioCentury
ARTICLE | Company News

CLGY, PIL manufacturing deal

August 21, 2001 7:00 AM UTC

PanGeo Pharma (TSE:PIL) will manufacture Tostrex testosterone gel, which is in Phase III trials to treat male hypogonadism, for Cellegy (CLGY). ...